Kawamoto, H., Tsugawa, K., Takishita, M., Tazo, M., Nakano, M.H., Tsuruga, T., Oi, R., Kuroda, T., Yoshie, R., Shimo, A., Iwatani, T., Shimo, A., Kojima, Y., Motoyoshi, A., Haku, E., Yabuki, Y., Suto, A., Kanemaki, Y., Mimura, H., Maeda, I. and Fukuda, M. (2021) VAB and MRI Following Percutaneous Ultra-Sound Guided Cryoablation for Primary Early-Stage Breast Cancer: A Pilot Study in Japan. Journal of Cancer Therapy, 12, 563-576. https://doi.org/10.4236/jct.2021.1210047
Summary: 8 female patients were enrolled, between the ages of 52- 72 years old (mean age 61.9) who were diagnosed with invasive ductal carcinoma (IDC) tumors and treated with percutaneous ultrasound-guided cryoablation. All patients received radiation and endocrine therapies. No residual or recurrent malignancies were detected. The study authors concluded that “percutaneous cryoablation of early-stage low-risk breast cancer tumors smaller than 15mm potentially presents a potential substitute for lumpectomy.”
***Full article may require purchase***